This MedLibrary.org supplementary page on 3i is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
| Type | Public company (LSE: III) |
|---|---|
| Founded | 1945 (created by a syndicate of British banks) |
| Headquarters | |
| Key people | Baroness Hogg, Chairman Philip Yea, CEO |
| Industry | Venture capital and Private equity |
| Revenue | £1,041m (2008) |
| Operating income | ▲ £834m (2008) |
| Net income | ▲ £828m (2008) |
| Employees | 765 (2007) |
| Website | www.3i.com |
3i Group PLC (LSE: III) is a leading venture capital and private equity firm. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.
Contents |
History
The company was formed in 1945, as the Industrial and Commercial Finance Corporation (ICFC), by the Bank of England and the major British banks to provide long term investment funding for small and medium-sized enterprises. Its foundation was inspired by the government, and resulted from the recognition in the 1930s, given new impetus in the postwar era, that smaller businesses faced a gap in available corporate finance: the banks were unwilling to provide long-term capital and the companies were too small to raise capital from the public markets.
During the 1950s and 1960s, particularly after 1959 when the shareholder banks allowed it to raise external funds, ICFC expanded to become the largest provider of venture capital for unquoted companies in the United Kingdom. In 1973 ICFC acquired Finance Corporation for Industry, a sister company also formed in 1945 which focused on finance for large companies, and was renamed Finance for Industry (FFI). In the 1980s FFI became a leading provider of finance for management buyouts, and expanded internationally. In 1983 the company was renamed Investors in Industry, commonly known as 3i.
3i Group was created in 1987 when the banks sold off their stakes to form a public limited company. In 1994 the company was floated on the London Stock Exchange with a market capitalization of £1.5 billion.1 Until that time the company had only managed its own portfolio of investments, but in 1994 the company began managing funds for external investors. Since that time the company has continued its international expansion, making a number of acquisitions in Europe and more recently starting operations in Asia.
Operations
The company undertakes buyouts, growth capital investments, infrastructure investments and quoted private equity.
Notable current investments
Current investments include:
- NCP: this investment was acquired in July 2005 from from Cinven. 3i has since entered into a partial sale of that business.2
- Scandlines: on June 19 2007, Deutsche Bahn AG and the Danish transport ministry announced the sale of Scandlines for 1,560 million Euros to a consortium consisting of 3i, Allianz Capital Partners and Deutsche Seereederei (DSR) Rostock. DSR will hold 20%, 3i and Allianz both 40%.3
- Agent Provocateur: in November 2007 3i acquired the lingerie business.4
- Foster and Partners: 3i acquired a minority (growth capital) stake in the architecture practice in May 2007.5
References
External links
|
|||||||||||||||||
|
|||||||||||
Wikipedia content modification information:
- This page was last modified on 7 December 2008, at 23:15.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "3i".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.
